Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Bumble
BMBL
$370M
| $20.8M | ﹤0.01% |
2,551,104
+2,333,489
| +1,072% | +$18M |
|
2102
Equinor
EQNR
$102B
| $20.8M | ﹤0.01% |
876,529
+245,498
| +39% | +$5.9M |
|
2103
Cboe Global Markets
CBOE
$31.4B
| $20.7M | ﹤0.01% |
105,958
+2,083
| +2% | +$429K |
|
2104
CALL
Entergy
ETR
$48.8B
| $20.7M | ﹤0.01% |
273,000
+19,400
| +8% | +$1.4M |
|
2105
PTC Therapeutics
PTCT
$5.83B
| $20.7M | ﹤0.01% |
458,015
+218,886
| +92% | +$9.37M |
|
|
2106
PUT
Cboe Global Markets
CBOE
$31.4B
| $20.7M | ﹤0.01% |
105,800
+11,000
| +12% | +$2.27M |
|
2107
Core Scientific
CORZ
$5.72B
| $20.6M | ﹤0.01% |
1,469,378
+282,651
| +24% | +$4.18M |
|
2108
PUT
Xerox
XRX
$381M
| $20.6M | ﹤0.01% |
2,444,400
+2,162,700
| +768% | +$19.9M |
|
2109
CALL
CSX Corp
CSX
$95.6B
| $20.6M | ﹤0.01% |
638,500
-618,200
| -49% | -$21.2M |
|
2110
Klaviyo
KVYO
$5.22B
| $20.6M | ﹤0.01% |
499,346
+86,086
| +21% | +$3.29M |
|
2111
PUT
Lithia Motors
LAD
$8.15B
| $20.6M | ﹤0.01% |
57,600
+37,800
| +191% | +$13.3M |
|
2112
IAMGOLD
IAG
$12.1B
| $20.6M | ﹤0.01% |
3,989,770
-612,431
| -13% | -$3.27M |
|
2113
PUT
Lumentum
LITE
$77.7B
| $20.6M | ﹤0.01% |
245,200
+103,700
| +73% | +$8.08M |
|
2114
NOV
NOV
$7.28B
| $20.6M | ﹤0.01% |
1,409,520
+283,208
| +25% | +$4.42M |
|
2115
CALL
Kenvue
KVUE
$36.6B
| $20.5M | ﹤0.01% |
958,900
-124,000
| -11% | -$2.81M |
|
2116
Ares Capital
ARCC
$14.3B
| $20.5M | ﹤0.01% |
934,640
+638,056
| +215% | +$13.8M |
|
2117
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
| $20.4M | ﹤0.01% |
35,900
-21,700
| -38% | -$12.7M |
|
2118
PUT
iShares MSCI South Korea ETF
EWY
$27.9B
| $20.4M | ﹤0.01% |
401,800
+239,200
| +147% | +$13.9M |
|
2119
PUT
Phillips 66
PSX
$96.9B
| $20.4M | ﹤0.01% |
179,400
-66,700
| -27% | -$8.49M |
|
2120
Skyworks Solutions
SWKS
$10.1B
| $20.4M | ﹤0.01% |
230,232
+147,441
| +178% | +$13.4M |
|
|
LB
2121
LandBridge Co
LB
$2.55B
| $20.4M | ﹤0.01% |
+321,523
| New | +$19.3M |
|
2122
Citizens Financial Group
CFG
$29.4B
| $20.3M | ﹤0.01% |
464,883
+224,724
| +94% | +$9.94M |
|
2123
Pacer Global Cash Cows Dividend ETF
GCOW
$3.57B
| $20.2M | ﹤0.01% |
+600,041
| New | +$21.1M |
|
2124
PUT
iShares MSCI China ETF
MCHI
$6.3B
| $20.2M | ﹤0.01% |
432,000
+233,100
| +117% | +$11.5M |
|
2125
CALL
Emcor
EME
$34.3B
| $20.2M | ﹤0.01% |
44,500
-27,300
| -38% | -$12.9M |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.